Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Future Med Chem ; 16(1): 11-26, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-38084595

RESUMO

Aim: Our objective was to investigate the trypanocidal effect of the chalcone (2E,4E)-1-(2-hydroxy-3,4,6-trimethoxyphenyl)-5-phenylpenta-2,4-dien-1-one (CPNC). Material & methods: Cytotoxicity toward LLC-MK2 host cells was assessed by MTT assay, and the effect on Trypanosoma cruzi life forms (epimastigotes, trypomastigotes and amastigotes) was evaluated by counting. Flow cytometry analysis was performed to evaluate the possible mechanisms of action. Finally, molecular docking simulations were performed to evaluate interactions between CPNC and T. cruzi enzymes. Results: CPNC showed activity against epimastigote, trypomastigote and amastigote life forms, induced membrane damage, increased cytoplasmic reactive oxygen species and mitochondrial dysfunction on T. cruzi. Regarding molecular docking, CPNC interacted with both trypanothione reductase and TcCr enzymes. Conclusion: CPNC presented a trypanocidal effect, and its effect is related to oxidative stress, mitochondrial impairment and necrosis.


Assuntos
Doença de Chagas , Chalconas , Tripanossomicidas , Trypanosoma cruzi , Humanos , Chalconas/farmacologia , Simulação de Acoplamento Molecular , Doença de Chagas/tratamento farmacológico , Espécies Reativas de Oxigênio , Tripanossomicidas/farmacologia
2.
Bioorg Chem ; 141: 106931, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-37879182

RESUMO

Chagas disease (CD) is a neglected tropical disease of worldwide health concern, caused by the flagellate protozoan Trypanosoma cruzi (T. cruzi), endemic in Latin America and present in North America and Europe. The WHO recommended drug for CD, benznidazole has low safety profile and several limitations. Therefore, an entity with better therapeutic potential to treat CD is required. Chalcones are an important class of compounds, which have shown antichagasic potential. Thus, the objective of this study was to evaluate the activity of synthetic p-aminochalcones against T. cruzi. Chalcones 1 and 2 were synthesized by Claisen-Schmidt condensation and characterized by both spectroscopic and theoretical methods. Initially, they were submitted to molecular docking simulations using cruzain and trypanothione reductase (TR) enzymes. It was expected to observe the possible interactions of chalcones with the catalytic site and other important regions of these main pharmacological targets of T. cruzi. Their cytotoxicity within host cells were assessed by MTT reduction assay using LLC-MK2 cells, with CC50 = 85.6 ± 9.2 µM and 1115 ± 381.7 µM for chalcones 1 and 2, respectively. These molecules were also tested against epimastigote and trypomastigote life forms of T. cruzi, causing reduction in the number of viable parasites. For the evaluation of the effect on intracellular amastigotes, infected LLC-MK2 cells were incubated with the chalcones for 24 h, causing reduction in the percentage of infected cells and the number of amastigotes/100 cells. Finally, flow cytometry assays were performed for analyzing cell death mechanisms (7-AAD/AxPE labelling), cytoplasmic ROS accumulation (DCFH-DA assay) and mitochondrial transmembrane potential disruption (Rho123 assay). Both chalcones (1 and 2) caused membrane damage, ROS accumulation and mitochondrial depolarization. In conclusion, the synthetic p-aminochalcones presented trypanocidal effect, causing membrane damage and oxidative stress. Their mechanism of action may be related to cruzain and TR inhibition.


Assuntos
Doença de Chagas , Chalconas , Tripanossomicidas , Trypanosoma cruzi , Humanos , Tripanossomicidas/química , Espécies Reativas de Oxigênio , Simulação de Acoplamento Molecular , Chalconas/farmacologia , Chalconas/uso terapêutico , Doença de Chagas/tratamento farmacológico
3.
Rev. colomb. biotecnol ; 25(1)jun. 2023.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1535720

RESUMO

Se ha estudiado la interacción entre antígenos ABO y microorganismos, incluidos los presentes en la microbiota, sobre la posible acción de antígenos y anticuerpos ABO en la susceptibilidad a enfermedades infecciosas. El objetivo de esta investigación fue determinar el título mínimo de la bacteria Escherichia coli capaz de sufrir la acción bactericida in vitro de los anticuerpos humanos anti-ABO. La selección de las muestras de sangre utilizadas se realizó mediante la aplicación de un cuestionario, fenotipado sanguíneo (un voluntario de cada fenotipo ABO) y la titulación de anticuerpos ABO. Se preparó una suspensión bacteriana (inoculo) y se agregó al suero de los voluntarios, seguido de la inoculación en Mueller Hinton Agar, luego de 24 horas, los resultados se leyeron e interpretaron con análisis por duplicado. No hubo diferencia significativa en la Prueba Bactericida entre las pruebas 1 y 2 en los grupos sanguíneos A, B, AB, O y Control Positivo. Hubo una diferencia significativa en el suero humano puro cuando se analizó el Grupo A x Control Positivo; Grupo B x Control Positivo; Grupo AB x Control Positivo y Grupo O x Control Positivo. No hubo diferencia significativa en las otras diluciones. Se concluye que los anticuerpos anti-ABO tienen efecto bactericida cuando existe una alta concentración de bacterias en el ambiente.


The interaction between ABO antigens and microorganisms, including those present in the microbiota, has been studied about the possible action of antigens and ABO antibodies in susceptibility to infectious diseases. This research aimed to determine the minimum titer of the Escherichia coli bacteria capable of undergoing in vitro bactericidal action of human anti-ABO antibodies. The selection of blood samples was performed through a questionnaire, blood phenotyping (one volunteer of each ABO phenotype), and the titration of ABO antibodies. A bacterial suspension (inoculum) was prepared and added to the serum of the volunteers, followed by inoculation in Mueller Hinton Agar. After 24 hours, the results were read and interpreted with duplicate analysis. There was no significant difference in the bactericidal test between tests 1 and 2 in blood groups A, B, AB, O, and Positive Control. There was a significant difference in pure human serum when Group A x Positive Control was analyzed, Group B x Positive Control, Group AB x Positive Control, and Group O x Positive Control. There was no significant difference in the other dilutions. It is concluded that anti-ABO antibodies have a bactericidal effect when there is a high concentration of bacteria in the environment.

4.
Ecotoxicology ; 31(8): 1299-1309, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-36136137

RESUMO

Leachate toxicity using bioindicators such as microcrustaceans and earthworms has not been fully elucidated. These bioindicators are traditionally determined through physicochemical and microbiological analyses. The ecotoxicological assessment of leachate using indicator organisms from different environments is a technique to ensure the treatment and safe disposal of this effluent with minimum impact on human health and the environment. The current study aimed to evaluate the ecotoxicological responses of Daphnia magna and Eisenia andrei in landfill leachate, identifying which organism was more sensitive to this effluent. The leachate used in ecotoxicological tests was collected at the Campina Grande Sanitary Landfill (ASCG), Paraíba, Brazil. The leachate sample contained a high content of organic matter in the form of chemical oxygen demand (19496.86 mg.L-1) and ammoniacal nitrogen (2198.00 mg.NL-1), in addition to metals with carcinogenic potential, such as Cr (0.64 mg.L-1) and Fe (1.16 mg.L-1). The exposure of Daphnia magna to the leachate showed that the effluent is harmful to aquatic organisms, obtaining an EC 50, 48 h = 1.22%, FT of 128 and a TU of 81.96%. Among the contaminant concentrations tested in Eisenia andrei, 57% (59.28 mL.kg-1) caused the highest lethality, causing the death of 21 earthworms within 72 hours of exposure. The avoidance test showed that exposure to leachate concentrations between 10.38 and 39.86 mL.kg-1 led to the leakage of earthworms, and habitat loss was observed at a concentration of 55.80 mL.kg-1, in which leak response (LR) ≥80% was obtained. This study demonstrates that the mentioned organisms are suitable for ecotoxicological tests in landfill leachate. Moreover, the microcrustacean Daphnia magna showed the most significant sensitivity, presenting a rapid ecotoxicological response to the leachate.


Assuntos
Oligoquetos , Poluentes Químicos da Água , Animais , Daphnia , Biomarcadores Ambientais , Humanos , Nitrogênio/análise , Poluentes Químicos da Água/análise
5.
Chem Biol Interact ; 361: 109920, 2022 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-35461787

RESUMO

Chagas disease is a disease that is emerging in North America and Europe countries. Benznidazole is the main drug available, but it has high toxicity and low efficacy in the chronic phase. In this way, researching new antichagasic agents is necessary. Thus, the aim of this study is to evaluate the effect of novel chalcones and the influence of chlorine substitutions on Trypanosoma cruzi and host cells. Unsubstituted (1), 4-chlorine substituted (2) and 2,4-chlorine substituted (3) chalcones were synthesized by Claisen-Schmidt condensation, characterized, and electrical distribution was assessed by Density Fuctional Theory (DFT). The host cells toxicity (LLC-MK2) was performed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) reduction assay. The effect on epimastigote (24, 48 and 72h), trypomastigote (24h) and amastigotes (24 h) was evaluated. Flow cytometry assays were performed with 7-Aminoactinomycin D (7-AAD) and Annexin-PE, Dichlorofluorescein diaceteate (DCFH-DA) and Rhodamine123 (Rho123). Finally, molecular docking predicted interactions between chalcones and cruzain (TcCr) and trypanothione reductase (TcTR). The toxicity on host cells was reduced almost twenty times on chlorine substituted molecules. On epimastigote and trypomastigote forms, all substances presented similar effects. After treatment with molecule 3, it was observed a decrease in infected cells and intracellular amastigotes. Their effect is related to necrotic events, increase of cytoplasmic Reactive Oxygen Species (ROS) and mitochondrial dysfunction. Also, this effect might be associated with involvement of TcCr and TcTR enzymes. Therefore, the results showed that chlorine substitution on chalcones reduces the host cell's toxicity without compromising the effect on Trypanosoma cruzi Y strain forms, and it occurs over membrane damage, oxidative stress and possible interactions with TcCr and TcTR.


Assuntos
Doença de Chagas , Chalcona , Chalconas , Tripanossomicidas , Trypanosoma cruzi , Doença de Chagas/tratamento farmacológico , Chalcona/farmacologia , Chalconas/farmacologia , Chalconas/uso terapêutico , Cloretos/farmacologia , Cloro , Humanos , Simulação de Acoplamento Molecular , Tripanossomicidas/farmacologia
6.
J Strength Cond Res ; 26(8): 2140-5, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22027847

RESUMO

The purpose of this investigation was to compare partial range-of-motion vs. full range-of-motion upper-body resistance training on strength and muscle thickness (MT) in young men. Volunteers were randomly assigned to 3 groups: (a) full range of motion (FULL; n = 15), (b) partial range of motion (PART; n = 15), or (c) control (CON; n = 10). The subjects trained 2 d · wk(-1) for 10 weeks in a periodized program. Primary outcome measures included elbow flexion maximal strength measured by 1 repetition maximum (1RM) and elbow flexors MT measured by ultrasound. The results indicated that elbow flexion 1RM significantly increased (p < 0.05) for the FULL (25.7 ± 9.6%) and PART groups (16.0 ± 6.7%) but not for the CON group (1.7 ± 5.5%). Also, FULL 1RM strength was significantly greater than the PART 1RM after the training period. Average elbow flexor MT significantly increased for both training groups (9.65 ± 4.4% for FULL and 7.83 ± 4.9 for PART). These data suggest that muscle strength and MT can be improved with both FULL and PART resistance training, but FULL may lead to greater strength gains.


Assuntos
Força Muscular/fisiologia , Músculo Esquelético/anatomia & histologia , Amplitude de Movimento Articular/fisiologia , Treinamento Resistido , Adolescente , Adulto , Cotovelo/diagnóstico por imagem , Cotovelo/fisiologia , Humanos , Masculino , Músculo Esquelético/fisiologia , Tamanho do Órgão , Ultrassonografia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA